查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1924742

旋轉切割動脈粥狀硬化斑塊切除術系統市場按技術、手術類型、產品類型、動力來源、適應症、應用和最終用戶分類－2026-2032年全球預測

Rotational Excisional Atherectomy System Market by Technology, Procedure Type, Product Type, Power Source, Indication, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年旋轉動脈粥狀硬化斑塊切除術系統市場價值為 3.5247 億美元，預計到 2026 年將成長至 3.8424 億美元，預計到 2032 年將達到 6.2548 億美元，複合年成長率為 8.53%。

關鍵市場統計數據
基準年 2025 3.5247億美元
預計年份：2026年 3.8424億美元
預測年份 2032 6.2548億美元
複合年成長率 (%) 8.53%

臨床需求和監管指南正在推動醫療機構中設備設計改進、證據產生和以價值為導向的採購決策。

旋轉切除動脈粥狀硬化斑塊切除術系統的發展格局正隨著臨床需求的不斷成長而演變，其促進因素包括手術複雜性的增加、器械的創新以及跨學科合作。過去幾年，臨床醫生一直在尋求能夠精準清除斑塊、同時最大限度地縮短手術時間並減少術後併發症的器械。這促使器械研發人員不斷改進切割頭幾何形狀、提升導管循跡性，並整合輔助技術以提高病變部位的通過率。因此，醫院和門診手術中心的決策者在評估新系統時，不僅關注其急性期性能指標，還關注整體手術流程、人員培訓要求以及與現有影像和血流動力學監測平台的兼容性。

設備工程、術中影像和醫療服務模式的創新正在融合，從而重塑技術應用路徑和商業性價值提案。

幾個變革性的轉折點正在加速動脈粥狀硬化斑塊切除術系統領域的發展。首先，器械材料和工程技術的迭代創新提高了器械的耐用性和精確度，使外科醫生能夠更可預測地治療更複雜、高度鈣化的病變。這項技術進步與擴展的術中成像功能相輔相成，包括血管內成像和混合透視/成像工作流程，這些功能共同實現了更精準的斑塊修飾，並減少了對經驗技術的依賴。其次，心血管手術擴大從住院轉向門診，這正在改變器械研發的重點，促使人們開發更緊湊、更易於操作的系統，以支持當日出院流程並減少手術全期資源的使用。第三，新的報銷模式和對器械相關成本日益嚴格的審查，正在將討論的焦點從簡單的購置價格轉移到綜合支付和基於治療結果的療效評估，這要求製造商證明其投資能夠帶來持續的臨床改善和手術效率的提升。

關稅驅動的供應鏈調整和透明的合約策略對於維持醫療設備的價格可負擔性和採購關係至關重要。

美國近期關稅政策的變化為供應鏈韌性和供應商選擇帶來了新的考量。對某些醫療設備零件和成品徵收的關稅增加了依賴跨境製造和零件採購的企業的到岸成本，促使採購部門重新評估供應商合約和總到岸成本的計算。為此，製造商正在加快部分製造業務的本地化進程，並從免稅地區尋找替代供應商，以確保供應的連續性並維持價格競爭力。這些供應鏈調整將影響有關前置作業時間、庫存策略和產能的資本配置決策。

多面向細分分析揭示了技術、流程類型、應用、最終用戶特徵、產品設計、電源和臨床適應症如何決定商業化路徑。

市場區隔框架揭示了臨床需求、技術發展和購買行為的交集，對這些細分市場的詳細分析有助於確定投資和商業化策略的優先順序。在基於技術的分類中，市場參與企業根據雷射和機械方法區分其產品，每種方法都意味著不同的設備面積、培訓路徑和臨床應用案例。在手術類型分類中，系統定位為軌道式或標準旋轉式技術，這會影響消融對稱性、管腔保留和設備扭矩動態等工程重點。基於適應症的產品藍圖涵蓋冠狀動脈和周邊血管適應症。冠狀動脈適應症進一步細分為急性冠狀動脈症候群和穩定性心絞痛，分別反映了不同的操作靈活性和病變特徵。同時，周邊血管適應症進一步細分為頸動脈和下肢適應症，每種適應症都有其獨特的解剖特徵和入路考量。

醫療基礎設施、報銷制度和手術量方面的區域差異，要求制定客製化的商業化策略和基於本地的證據生成方法。

區域趨勢表明，醫療基礎設施、報銷模式和臨床實踐模式的差異如何影響醫療器材的採用和市場優先排序。美洲地區擁有成熟的心血管專科中心生態系統、完善的上市後監測註冊系統，以及在冠狀動脈和周邊血管介入治療中較高的器械採用率。這推動了對能夠提供手術效率和臨床持久性證據的系統的需求。同時，歐洲、中東和非洲地區面臨不同的報銷環境以及高頻次三級醫療中心資源分配不均的問題。這有利於能夠適應各種臨床環境並能以最小的基礎設施變更整合到不同治療路徑中的多功能系統。該地區的多個司法管轄區都採用了集中採購和衛生技術評估 (HTA) 流程，因此，開發符合當地 HTA 要求的臨床和經濟證據對於加速器材的採用至關重要。

競爭優勢日益依賴整合的產品生態系統、臨床醫生培訓以及可靠的上市後證據，以支持產品的持續推廣應用。

旋轉切割動脈粥狀硬化斑塊切除術領域的公司競爭格局反映了其多樣化的策略選擇，從專注於特定器械類別到整合影像、耗材和服務等全方位產品組合，不一而足。主要企業正透過技術改進提高病變矯正精度、投資臨床醫生培訓基礎設施以及建立強大的上市後證據項目來支持其差異化價值主張，從而實現差異化競爭。與醫院系統、學術機構和契約製造夥伴關係和策略聯盟已成為常態，這使得企業能夠擴大臨床試驗規模並最佳化其製造地。

醫療設備製造商可透過協調投資和夥伴關係，採取切實可行的措施，提高臨床接受度、採購協調性和供應鏈韌性。

為了贏得臨床信任和採購優先權，醫療設備研發和商業化領域的領導企業應積極進行以下合作：首先，優先投資於與醫院管理者和支付方關注的終點指標（例如，手術效率、併發症減少和資源利用）相一致的、可靠的真實世界證據項目。其次，設計將實務技能培訓與數位化學習模組和遠距指導相結合的培訓課程，以加快從業人員的熟練度提升，同時最大限度地減少差旅和日程安排方面的負擔。第三，最佳化產品系列，明確區分一次性產品和可重複使用產品，並透明地展示生命週期成本，包括消毒、耗材需求和維護合約。

為了確保基於證據的見解，我們採用多方面的調查方法，整合了臨床醫生訪談、臨床文獻回顧、監管申報和競爭情報分析。

本次情報綜合調查方法採用多種互補方法，確保評估的全面性和客觀性。主要研究包括對介入性心臟病專家、血管外科醫生、採購人員、生物醫學工程師和臨床試驗負責人進行結構化訪談，以收集他們對器械性能、培訓需求和採購因素的現場觀點。這些定性研究結果與同行評審的臨床文獻、手術註冊數據和監管申報文件的系統性回顧相結合，以檢驗不同患者群體和解剖適應症的安全性和有效性訊號。

技術卓越、證據生成和商業性敏捷性的策略結合將決定不斷變化的醫療器材市場的最終贏家。

總而言之，由於技術進步、醫療服務模式轉變以及財務監管加強等因素，動脈粥狀硬化斑塊切除術系統領域正經歷快速變革。臨床醫師和採購團隊期望設備不僅能提高手術效果，還能大幅提升工作流程效率和後續資源利用率。優先考慮整合實證醫學證據、靈活產品設計和穩健供應鏈策略的製造商，將更有利於建立臨床信譽，並滿足不同醫療機構的營運需求。針對不同市場，採取區域性策略，並結合當地的衛生經濟環境和培訓項目，對於加速產品推廣至關重要。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依技術分類的旋轉切割動脈粥狀硬化斑塊切除術系統市場

  • 雷射
  • 機械的

9. 依手術類型分類的旋轉切割動脈粥狀硬化斑塊切除術系統市場

  • 軌道
  • 標準旋轉型

第10章 依產品類型分類的旋轉切割動脈粥狀硬化斑塊切除術系統市場

  • 一次性的
  • 可重複使用的

第11章 依動力來源的旋轉切割動脈粥狀硬化斑塊切除術系統市場

  • 電的
  • 氣動

12. 旋轉切割動脈粥狀硬化斑塊切除術系統市場（依適應症分類）

  • 鈣化病灶
  • 慢性完全閉塞

第13章 依應用分類的旋轉切割動脈粥狀硬化斑塊切除術系統市場

  • 冠狀動脈
    • 急性冠狀動脈症候群
    • 穩定性心絞痛
  • 周邊血管
    • 頸動脈
    • 下肢

第14章 以最終用戶分類的旋轉切割動脈粥狀硬化斑塊切除術系統市場

  • 門診手術中心
  • 診所
  • 醫院
    • 政府
    • 私人的

15. 旋轉切割動脈粥狀硬化斑塊切除術系統市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 旋轉切割動脈粥狀硬化斑塊切除術切除系統市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

17. 各國旋轉切割動脈粥狀硬化斑塊切除術系統市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

18. 美國旋轉切割動脈粥狀硬化斑塊切除術系統市場

第19章 中國旋轉切割斑塊動脈粥狀硬化斑塊切除術系統市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Avinger, Inc.
  • B. Braun SE
  • Bard Peripheral Vascular, Inc.
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cardiovascular Systems, Inc.
  • Cook Medical LLC
  • Koninklijke Philips NV
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Philips
  • Rex Medical, LP
  • SJM Subsidiary Inc.
  • Spectranetics Corporation
  • Stryker Corporation
  • Terumo Corporation
  • Volcano Corporation
Product Code: MRR-7A380DA7C46D

The Rotational Excisional Atherectomy System Market was valued at USD 352.47 million in 2025 and is projected to grow to USD 384.24 million in 2026, with a CAGR of 8.53%, reaching USD 625.48 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 352.47 million
Estimated Year [2026] USD 384.24 million
Forecast Year [2032] USD 625.48 million
CAGR (%) 8.53%

Clinical demand and regulatory stewardship are driving refinement of device design, evidence generation, and value-focused procurement decisions across care settings

The Rotational Excisional Atherectomy System landscape is shifting as procedural complexity, device innovation, and cross-disciplinary collaboration converge to meet escalating clinical needs. Over the past several years, clinicians have sought devices that deliver precise plaque modification while minimizing procedural time and reducing downstream complications. This has driven device developers to refine cutting-tip geometries, enhance catheter trackability, and integrate adjunctive technologies that improve lesion crossability. As a result, decision-makers in hospitals and outpatient surgical centers evaluate new systems not only on acute performance metrics but also on total procedure workflow, staff training requirements, and device compatibility with existing imaging and hemodynamic monitoring platforms.

Concurrent with clinical drivers, regulatory authorities have placed greater emphasis on real-world evidence and post-market surveillance to validate device safety across diverse patient populations. Manufacturers have thus intensified investments in clinical registries and investigator-initiated studies to support device adoption and to provide the data clinicians need to update protocols. Payers and procurement teams are increasingly interested in comparative outcomes and resource utilization data that demonstrate value beyond the index procedure, prompting cross-functional dialogues among cardiac surgery, interventional cardiology, vascular medicine, and hospital supply chain teams. Taken together, these dynamics are shaping a market where clinical effectiveness, ease of use, and total cost of care are central to commercial success.

Converging innovations in device engineering, procedural imaging, and care delivery models are reshaping adoption pathways and commercial value propositions

Several transformative inflection points are accelerating change in the atherectomy systems space. First, iterative innovations in device materials and engineering have enhanced durability and precision, allowing operators to treat more complex and heavily calcified lesions with greater predictability. This technical progress is complemented by expanded procedural imaging capabilities, including intravascular imaging and hybrid fluoroscopic-imaging workflows, which together enable more targeted plaque modification and reduce reliance on empirical technique. Second, the increasing migration of cardiovascular procedures from inpatient to outpatient settings has influenced device development priorities, promoting compact, easier-to-manage systems that support same-day discharge pathways and reduced peri-procedural resource use. Third, new reimbursement models and heightened scrutiny over device-related costs have shifted conversations from acquisition price alone to bundled payment and episode-based performance, pushing manufacturers to document durable clinical improvements and return on procedural efficiency.

Moreover, an evolving competitive environment is fostering greater strategic alignment between device suppliers and clinical champions; partnerships now frequently include co-developed training curricula, virtual proctoring, and integrated post-market data collection to accelerate user proficiency and capture meaningful outcomes. Finally, demographic trends such as aging populations and the rising prevalence of diabetes and chronic kidney disease are increasing the prevalence of complex peripheral and coronary calcification, expanding the clinical imperative for more effective lesion modification solutions. These shifts are collectively reorienting product roadmaps, clinical trial designs, and commercial models toward more evidence-driven, procedure-centric offerings that can demonstrate measurable benefits in increasingly constrained healthcare budgets.

Tariff-driven supply chain adaptations and transparent contracting strategies are becoming pivotal to preserve device affordability and procurement relationships

The recent tariff environment in the United States has introduced new considerations for supply chain resilience and vendor selection. Tariffs on select medical device inputs and finished devices have elevated landed costs for companies that rely on cross-border manufacturing and component sourcing, prompting procurement teams to re-evaluate vendor contracts and total landed cost calculations. In response, manufacturers have accelerated efforts to localize certain manufacturing steps or to source alternate suppliers from tariff-exempt jurisdictions, thereby preserving competitive pricing while ensuring supply continuity. These supply chain adjustments have implications for lead times, inventory strategies, and capital allocation decisions for production capacity.

Additionally, the tariff-driven cost pressures have encouraged many sellers to pursue increased transparency in pricing and to develop flexible contracting arrangements that share risk with hospitals and group purchasing organizations. Some manufacturers have introduced consignment models, rolling inventory agreements, or multi-year fixed-price contracts to mitigate procurement uncertainty. From the clinical perspective, hospitals are prioritizing devices that demonstrate operational predictability and minimal requirement for supplementary disposables, since variability in accessory needs can magnify the financial impact of tariffs. Consequently, companies that can articulate a coherent plan to manage tariff exposure, while maintaining product quality and timely delivery, are positioned to strengthen relationships with major healthcare systems and to protect installed-base loyalty.

A multifaceted segmentation lens reveals how technology, procedure type, application, end-user profile, product design, power source, and clinical indication define commercialization pathways

The market segmentation framework illuminates where clinical need, technical development, and purchasing behavior intersect, and a nuanced read of these segments helps prioritize investment and commercialization strategies. Based on Technology, market participants are differentiating offerings across Laser and Mechanical modalities, with each pathway implying distinct capital equipment footprints, training pathways, and clinical use cases. Based on Procedure Type, systems are positioned for Orbital or Standard Rotational techniques, which influences engineering priorities such as ablation symmetry, lumen preservation, and device torque dynamics. Based on Application, product roadmaps address Coronary and Peripheral indications; the Coronary cohort is further refined into Acute Coronary Syndrome and Stable Angina, reflecting different urgency profiles and lesion characteristics, while the Peripheral cohort is further subdivided into Carotid and Lower Extremity applications, each carrying unique anatomic and access considerations.

Based on End User, purchasing and implementation vary across Ambulatory Surgical Centers, Clinics, and Hospitals; within Hospitals, procurement dynamics differ between Government and Private institutions, with implications for tendering processes and compliance. Based on Product Type, there is a clear delineation between Disposable and Reusable offerings, each presenting trade-offs in per-case cost, sterilization logistics, and device lifecycle planning. Based on Power Source, Electric and Pneumatic configurations present divergent operating requirements and maintenance profiles, which intersect with hospital infrastructure and biomedical engineering capabilities. Finally, based on Indication, devices are tailored for Calcified Lesions or Chronic Total Occlusion, and this clinical focus determines the extent of adjunctive imaging, cutting or ablation modalities, and operator training programs required to achieve reproducible outcomes. Understanding these segmentation axes enables targeted clinical studies, refined value messaging, and differentiated service models that align product features with the purchasing realities of end users.

Regional variations in healthcare infrastructure, reimbursement, and procedural volume necessitate tailored commercialization strategies and localized evidence generation

Regional dynamics demonstrate how differing healthcare infrastructure, reimbursement paradigms, and clinical practice patterns shape device adoption and market prioritization. In the Americas, there is a mature ecosystem of specialized cardiovascular centers, robust post-market registries, and a high degree of device uptake across both coronary and peripheral interventions; this drives demand for systems that offer procedural efficiency and evidence of clinical durability. In contrast, Europe, Middle East & Africa exhibit heterogeneous reimbursement landscapes and variable access to high-volume tertiary centers, which favors versatile systems that accommodate a wide range of clinical environments and that can be integrated into different care pathways with minimal infrastructure changes. In several jurisdictions across this region, centralized procurement and health technology assessment processes mean that clinical and economic evidence must be tailored to local HTA requirements to facilitate adoption.

Asia-Pacific demonstrates strong growth in procedural volumes driven by demographic shifts and rising investment in cardiovascular care capacity, and the region presents opportunities for scalable training programs and localized manufacturing partnerships that can lower delivery costs and improve market responsiveness. Across all regions, regulatory harmonization efforts and international clinical collaborations are moderating adoption timelines, but local reimbursement and practice patterns remain key determinants of where and how new systems are deployed. Consequently, commercial strategies should be regionally calibrated, balancing global evidence generation with locally relevant health economic narratives and training modalities that reflect provider workflows and infrastructure maturity.

Competitive differentiation increasingly hinges on integrated product ecosystems, clinician training, and robust post-market evidence to support durable adoption

The competitive profile of companies in the rotational excisional atherectomy domain reflects a spectrum of strategic choices, from specialization in narrow device classes to broad portfolios that integrate imaging, consumables, and service offerings. Leading companies differentiate through engineering refinements that enhance lesion modification precision, through investments in clinician training infrastructure, and through the assembly of robust post-market evidentiary programs that support differential value claims. Partnerships and strategic collaborations with hospital systems, academic centers, and contract manufacturers have become routine, enabling firms to scale clinical studies and to optimize manufacturing footprints.

Some companies emphasize modular systems that allow incremental upgrades and compatibility with existing cath lab equipment, reducing the friction for adoption. Others focus on disposable-centric strategies that simplify logistics for outpatient centers and reduce sterilization burdens. Service models also vary, with several players introducing remote proctoring, virtual training, and integrated data-collection platforms that tie procedural metrics to outcomes. For purchasers, competitive positioning is not only about device performance but also about the totality of support - training, warranty, and evidence generation. Firms that can demonstrate a cohesive ecosystem around their devices, including clear plans for regulatory compliance and long-term product stewardship, tend to build stronger clinical loyalty and more defensible commercial differentiation.

Actionable initiatives for device makers to strengthen clinical acceptance, procurement alignment, and supply chain resilience through coordinated investments and partnerships

Leaders in device development and commercialization should pursue a coordinated set of actions to capture clinical trust and procurement preference. First, prioritize investments in robust real-world evidence programs that align with the endpoints hospital administrators and payers value, such as procedural efficiency, complication reduction, and resource utilization. Second, design training curricula that combine hands-on skill development with digital learning modules and remote proctoring to accelerate operator competence while minimizing travel and scheduling burdens. Third, optimize product portfolios to offer clear contrasts between disposable and reusable models, and provide transparent lifecycle costing that addresses sterilization, consumable needs, and maintenance commitments.

Additionally, manufacturing resilience should be enhanced by diversifying supply bases and considering localized production for critical subassemblies to reduce exposure to tariff volatility and shipping disruptions. Commercial and clinical affairs teams should co-develop value dossiers and HTA-ready materials customized to priority regions, enabling faster reimbursement conversations and procurement approvals. Finally, invest in interoperable data platforms that link procedural metrics with patient outcomes, as this capability will become a decisive differentiator in payer discussions and hospital procurement committees. These actions, executed in parallel, will strengthen market access, improve clinician satisfaction, and create defensible competitive advantages.

A multi-method research approach integrating clinician interviews, clinical literature review, regulatory filings, and competitive intelligence to ensure evidence-based insights

The research methodology for this intelligence synthesis combined multiple complementary approaches to ensure a comprehensive and objective assessment. Primary research included structured interviews with interventional cardiologists, vascular surgeons, procurement executives, biomedical engineers, and clinical trialists to capture frontline perspectives on device performance, training needs, and purchasing drivers. These qualitative inputs were triangulated with a systematic review of peer-reviewed clinical literature, procedural registries, and regulatory filings to validate safety and effectiveness signals across a diversity of patient populations and anatomical applications.

Secondary research entailed analysis of public clinical trial registries, device approvals, and product IFUs to map device capabilities and indications. Competitive intelligence was gathered through product literature, investor presentations, and publicly available manufacturing footprints to understand strategic positioning and supply chain characteristics. To preserve rigor, data synthesis applied an evidence-weighting protocol prioritizing randomized and prospective registries for clinical claims while using real-world operational data to inform adoption and procedural workflow insights. Finally, expert validation panels reviewed interim findings to refine interpretation, highlight regional differences, and ensure the narrative accurately reflects clinical practice patterns and procurement dynamics.

Strategic convergence of engineering excellence, evidence generation, and commercial agility will determine winners in the evolving device landscape

In summary, the environment for rotational excisional atherectomy systems is evolving rapidly under the influence of technological refinement, shifting care delivery models, and heightened fiscal scrutiny. Clinicians and procurement teams now expect devices to deliver not only procedural efficacy but also demonstrable improvements in workflow efficiency and downstream resource utilization. Manufacturers that prioritize integrated evidence generation, flexible product design, and resilient supply chain strategies will be better positioned to establish clinical credibility and to meet the operational needs of a range of care settings. Region-specific approaches, supported by locally relevant health economic narratives and training programs, will be critical to accelerating adoption in diverse markets.

Moving forward, stakeholders should treat device introduction as a coordinated program that aligns engineering, clinical education, evidence planning, and commercial contracting. Doing so will reduce adoption friction, improve patient-centric outcomes, and enable procurement partners to make informed choices that reflect both clinical value and system-level financial constraints. The convergence of better engineered devices, richer clinical data, and adaptive commercial models presents a strategic opening for companies that can execute across these domains with discipline and clinical partnership.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Rotational Excisional Atherectomy System Market, by Technology

  • 8.1. Laser
  • 8.2. Mechanical

9. Rotational Excisional Atherectomy System Market, by Procedure Type

  • 9.1. Orbital
  • 9.2. Standard Rotational

10. Rotational Excisional Atherectomy System Market, by Product Type

  • 10.1. Disposable
  • 10.2. Reusable

11. Rotational Excisional Atherectomy System Market, by Power Source

  • 11.1. Electric
  • 11.2. Pneumatic

12. Rotational Excisional Atherectomy System Market, by Indication

  • 12.1. Calcified Lesions
  • 12.2. Chronic Total Occlusion

13. Rotational Excisional Atherectomy System Market, by Application

  • 13.1. Coronary
    • 13.1.1. Acute Coronary Syndrome
    • 13.1.2. Stable Angina
  • 13.2. Peripheral
    • 13.2.1. Carotid
    • 13.2.2. Lower Extremity

14. Rotational Excisional Atherectomy System Market, by End User

  • 14.1. Ambulatory Surgical Centers
  • 14.2. Clinics
  • 14.3. Hospitals
    • 14.3.1. Government
    • 14.3.2. Private

15. Rotational Excisional Atherectomy System Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Rotational Excisional Atherectomy System Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Rotational Excisional Atherectomy System Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Rotational Excisional Atherectomy System Market

19. China Rotational Excisional Atherectomy System Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Abbott Laboratories
  • 20.6. Avinger, Inc.
  • 20.7. B. Braun SE
  • 20.8. Bard Peripheral Vascular, Inc.
  • 20.9. Boston Scientific Corporation
  • 20.10. Cardinal Health, Inc.
  • 20.11. Cardiovascular Systems, Inc.
  • 20.12. Cook Medical LLC
  • 20.13. Koninklijke Philips N.V.
  • 20.14. Medtronic plc
  • 20.15. Merit Medical Systems, Inc.
  • 20.16. Philips
  • 20.17. Rex Medical, LP
  • 20.18. SJM Subsidiary Inc.
  • 20.19. Spectranetics Corporation
  • 20.20. Stryker Corporation
  • 20.21. Terumo Corporation
  • 20.22. Volcano Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY POWER SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY LASER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY LASER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY LASER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY MECHANICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY ORBITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY ORBITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY ORBITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY STANDARD ROTATIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY STANDARD ROTATIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY STANDARD ROTATIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY ELECTRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY ELECTRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY ELECTRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PNEUMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PNEUMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PNEUMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CALCIFIED LESIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CALCIFIED LESIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CALCIFIED LESIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CORONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CORONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY STABLE ANGINA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY STABLE ANGINA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY STABLE ANGINA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CAROTID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CAROTID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CAROTID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY LOWER EXTREMITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY LOWER EXTREMITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY LOWER EXTREMITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY GOVERNMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY GOVERNMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 176. GCC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GCC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. GCC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. GCC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. GCC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 181. GCC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 182. GCC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. GCC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 184. GCC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 185. GCC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. GCC ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 209. G7 ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. G7 ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 211. G7 ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. G7 ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. G7 ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 214. G7 ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 215. G7 ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. G7 ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 217. G7 ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 218. G7 ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. G7 ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 220. NATO ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. NATO ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. NATO ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. NATO ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. NATO ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 225. NATO ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 226. NATO ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. NATO ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 228. NATO ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 229. NATO ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. NATO ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA ROTATIONAL EXCISIONAL ATHERECTOMY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)